• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童烟雾病:回顾与展望。

Childhood Moyamoya: Looking Back to the Future.

机构信息

Department of Neurology, The Hospital for Sick Children, Toronto, Canada.

Neuroradiology, Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Canada.

出版信息

Pediatr Neurol. 2019 Feb;91:11-19. doi: 10.1016/j.pediatrneurol.2018.10.006. Epub 2018 Oct 15.

DOI:10.1016/j.pediatrneurol.2018.10.006
PMID:30424960
Abstract

Moyamoya is a chronic, progressive steno-occlusive arteriopathy that typically affects the anterior circulation arteries of the circle of Willis. A network of deep thalamoperforating and lenticulostriate collaterals develop to by-pass the occlusion giving rise to the characteristic angiographic "puff of smoke" appearance. Moyamoya confers a lifelong risk of stroke and neurological demise, with peak age of presentation in childhood ranging between five and 10 years. Moyamoya disease refers to patients who do not have a comorbid condition, whereas moyamoya syndrome refers to patients in whom moyamoya occurs in association with an acquired or inherited disorder such as sickle cell disease, neurofibromatosis type-1 or trisomy 21. The incidence of moyamoya disease and moyamoya syndrome demonstrates geographic and ethnic variation, with a predominance of moyamoya disease in East-Asian populations. Antiplatelet therapy and surgical revascularization procedures are the mainstay of management, as there are no available treatments to slow the progression of the arteriopathy. Future research is required to address the major gaps that remain in our understanding of the pathologic basis, optimal timing for surgery, and determinants of outcome in this high-stroke risk condition of childhood.

摘要

烟雾病是一种慢性进行性狭窄闭塞性血管病,通常影响 Willis 环的前循环动脉。为了绕过闭塞,深穿通支和纹状体动脉会形成侧支循环,从而导致特征性的血管造影“烟雾状”外观。烟雾病会导致终身中风和神经功能丧失的风险,发病的高峰年龄在 5 至 10 岁之间。烟雾病是指没有合并症的患者,而烟雾病综合征是指烟雾病发生在镰状细胞病、神经纤维瘤病 1 型或 21 三体等获得性或遗传性疾病的患者中。烟雾病和烟雾病综合征的发病率存在地域和种族差异,东亚人群中烟雾病更为常见。抗血小板治疗和手术血运重建是主要的治疗方法,因为目前尚无治疗方法可以减缓血管病变的进展。未来需要研究来解决我们在病理基础、手术最佳时机以及这种高中风风险儿童疾病结局决定因素方面的理解方面存在的主要差距。

相似文献

1
Childhood Moyamoya: Looking Back to the Future.儿童烟雾病:回顾与展望。
Pediatr Neurol. 2019 Feb;91:11-19. doi: 10.1016/j.pediatrneurol.2018.10.006. Epub 2018 Oct 15.
2
Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.儿童大脑 Willis 环自发性闭塞:小儿烟雾病总结及循证实践指南建议。一篇综述。
J Neurosurg Pediatr. 2012 Apr;9(4):353-60. doi: 10.3171/2011.12.PEDS1172.
3
ACTA2 Cerebral Arteriopathy: Not Just a Puff of Smoke.ACTA2 相关性脑动脉病:并非只是一缕轻烟。
Cerebrovasc Dis. 2018;46(3-4):161-171. doi: 10.1159/000493863. Epub 2018 Oct 9.
4
Moyamoya disease: a summary.烟雾病:综述
Neurosurg Focus. 2009 Apr;26(4):E11. doi: 10.3171/2009.1.FOCUS08310.
5
Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.与1型神经纤维瘤病相关的烟雾综合征:手术血运重建后的围手术期及长期预后
J Neurosurg Pediatr. 2013 Apr;11(4):417-25. doi: 10.3171/2012.12.PEDS12281. Epub 2013 Feb 1.
6
Management of moyamoya disease: a review of current and future therapeutic strategies.烟雾病的治疗:当前及未来治疗策略综述
J Neurosurg. 2024 Apr 19;141(4):975-982. doi: 10.3171/2024.1.JNS221977. Print 2024 Oct 1.
7
Advances and surgical considerations in the treatment of moyamoya disease.在治疗烟雾病方面的进展和手术考虑。
Neurosurgery. 2014 Feb;74 Suppl 1:S116-25. doi: 10.1227/NEU.0000000000000229.
8
Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine.考纳斯医科大学神经外科诊所治疗烟雾病的经验。
Medicina (Kaunas). 2006;42(2):130-6.
9
Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.烟雾病综合征和镰状细胞贫血患者的软脑膜血管吻合术:围手术期管理及手术结果
Neurosurg Focus. 2009 Apr;26(4):E10. doi: 10.3171/2009.01.FOCUS08307.
10
Surgery for Moyamoya Disease in Children.儿童烟雾病的外科治疗
J Child Neurol. 2019 Aug;34(9):517-529. doi: 10.1177/0883073819844854. Epub 2019 May 8.

引用本文的文献

1
Plasma extracellular vesicle-associated miR-512-3p modulates angiogenesis in pediatric Moyamoya disease by targeting ARHGEF3.血浆细胞外囊泡相关的miR-512-3p通过靶向ARHGEF3调节小儿烟雾病中的血管生成。
Sci Rep. 2025 Jul 9;15(1):24655. doi: 10.1038/s41598-025-08796-4.
2
Moyamoya Disease: Advances in Diagnosis, Treatment, and Surgical Interventions.烟雾病:诊断、治疗及手术干预的进展
Cureus. 2024 May 7;16(5):e59826. doi: 10.7759/cureus.59826. eCollection 2024 May.
3
Relative anemia and perioperative stroke in children with moyamoya.
儿童烟雾病相关贫血与围手术期卒中。
J Stroke Cerebrovasc Dis. 2024 Jan;33(1):107476. doi: 10.1016/j.jstrokecerebrovasdis.2023.107476. Epub 2023 Nov 15.
4
Seizures in Pediatric Moyamoya: Risk Factors and Functional Outcomes.小儿烟雾病的癫痫发作:危险因素与功能预后
Pediatr Neurol. 2023 Aug;145:36-40. doi: 10.1016/j.pediatrneurol.2023.04.025. Epub 2023 May 8.
5
Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke.小儿动脉缺血性脑卒中的诊治进展。
Neurotherapeutics. 2023 Apr;20(3):633-654. doi: 10.1007/s13311-023-01373-5. Epub 2023 Apr 18.
6
The Pathogenetic Mechanism for Moyamoya Vasculopathy Including a Possible Trigger Effect of Increased Flow Velocity.烟雾病血管病变的发病机制,包括血流速度增加可能产生的触发效应。
JMA J. 2023 Jan 16;6(1):16-24. doi: 10.31662/jmaj.2022-0104. Epub 2022 Dec 19.
7
Vessel Wall Changes on Serial High-Resolution MRI and the Use of Cilostazol in Patients With Adult-Onset Moyamoya Disease.成人烟雾病患者连续高分辨率磁共振成像的血管壁变化及西洛他唑的应用
J Clin Neurol. 2022 Nov;18(6):610-618. doi: 10.3988/jcn.2022.18.6.610.
8
Angioarchitectural Factors Associated with Postoperative Cerebral Infarction in Ischemic Moyamoya Disease.缺血性烟雾病术后脑梗死相关的血管构筑因素
Brain Sci. 2022 Sep 20;12(10):1270. doi: 10.3390/brainsci12101270.
9
RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.一名患有与烟雾病综合征相关的勒吉尤斯综合征患者的RNF213基因变异
Mol Genet Genomic Med. 2021 Jun;9(6):e1669. doi: 10.1002/mgg3.1669. Epub 2021 May 3.
10
Moyamoya Syndrome in a 32-Year-Old Male With Sickle Cell Anemia.一名32岁镰状细胞贫血男性患者的烟雾病综合征
Cureus. 2020 Aug 24;12(8):e10001. doi: 10.7759/cureus.10001.